Literature DB >> 10834975

PCR-Based quantification of Borrelia burgdorferi organisms in canine tissues over a 500-Day postinfection period.

R K Straubinger1.   

Abstract

Borrelia burgdorferi infection in beagle dogs was studied quantitatively with skin punch biopsy samples and blood samples collected at 4- and 2-week intervals, respectively, over a 500-day period. Thereafter, 25 tissue samples of each dog were collected for further analysis. Starting at day 120 after tick challenge, 12 dogs were treated with antibiotics (azithromycin, ceftriaxone, or doxycycline) for 30 consecutive days. Four dogs received no antibiotic therapy. Quantification of B. burgdorferi DNA was done with an ABI Prism 7700 Sequence Detection System with oligonucleotide primers and a fluorescence-labeled probe designed to specifically amplify a fragment of the ospA gene of B. burgdorferi strain N40. All 16 dogs became infected with B. burgdorferi after tick challenge. In skin biopsy samples, spirochete numbers peaked at day 60 postinfection (<1.5 x 10(6) organisms per 100 microgram of extracted DNA), at the same time when clinical signs of arthritis developed in 11 of 16 dogs, and decreased to almost undetectable levels during the following 6 months. The number of B. burgdorferi organisms detected in skin biopsy samples was inversely correlated with the antibody levels measured by enzyme-linked immunosorbent assay. Antibiotic treatment reduced the amount of detectable spirochete DNA in skin tissue by a factor of 1,000 or more. At the end of the experiment, B. burgdorferi DNA was detectable at low levels (10(2) to 10(4) organisms per 100 microgram of extracted DNA) in multiple tissue samples regardless of treatment. However, more tissue samples of untreated dogs than of antibiotic-treated dogs were positive, and tissue samples of untreated dogs also were positive by culture. Only 1.6% of 576 blood samples of all dogs were positive for B. burgdorferi by PCR.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10834975      PMCID: PMC86761          DOI: 10.1128/JCM.38.6.2191-2199.2000

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

1.  Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment.

Authors:  R K Straubinger; B A Summers; Y F Chang; M J Appel
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

2.  A two year prospective study to compare culture and polymerase chain reaction amplification for the detection and diagnosis of Lyme borreliosis.

Authors:  M M Picken; R N Picken; D Han; Y Cheng; E Ruzic-Sabljic; J Cimperman; V Maraspin; S Lotric-Furlan; F Strle
Journal:  Mol Pathol       Date:  1997-08

3.  Transformation of cystic forms of Borrelia burgdorferi to normal, mobile spirochetes.

Authors:  O Brorson; S H Brorson
Journal:  Infection       Date:  1997 Jul-Aug       Impact factor: 3.553

4.  Borrelia burgdorferi migrates into joint capsules and causes an up-regulation of interleukin-8 in synovial membranes of dogs experimentally infected with ticks.

Authors:  R K Straubinger; A F Straubinger; L Härter; R H Jacobson; Y F Chang; B A Summers; H N Erb; M J Appel
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

5.  Bloodstream invasion in early Lyme disease: results from a prospective, controlled, blinded study using the polymerase chain reaction.

Authors:  J L Goodman; J F Bradley; A E Ross; P Goellner; A Lagus; B Vitale; B W Berger; S Luger; R C Johnson
Journal:  Am J Med       Date:  1995-07       Impact factor: 4.965

Review 6.  Treatment failure in erythema migrans--a review.

Authors:  K Weber
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

7.  In vitro conversion of Borrelia burgdorferi to cystic forms in spinal fluid, and transformation to mobile spirochetes by incubation in BSK-H medium.

Authors:  O Brorson; S H Brorson
Journal:  Infection       Date:  1998 May-Jun       Impact factor: 3.553

8.  Comparison of the ABI 7700 system (TaqMan) and competitive PCR for quantification of IS6110 DNA in sputum during treatment of tuberculosis.

Authors:  L E Desjardin; Y Chen; M D Perkins; L Teixeira; M D Cave; K D Eisenach
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

9.  Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization.

Authors:  K J Livak; S J Flood; J Marmaro; W Giusti; K Deetz
Journal:  PCR Methods Appl       Date:  1995-06

Review 10.  Immunity to Lyme disease: protection, pathology and persistence.

Authors:  K P Seiler; J J Weis
Journal:  Curr Opin Immunol       Date:  1996-08       Impact factor: 7.486

View more
  44 in total

1.  Use of quantitative PCR to measure density of Borrelia burgdorferi in the midgut and salivary glands of feeding tick vectors.

Authors:  J Piesman; B S Schneider; N S Zeidner
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

2.  Clinical findings associated with Borrelia burgdorferi infection in the dog.

Authors:  E Giudice; F Domina; D Britti; S Di Pietro; A Pugliese
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

3.  Borrelia burgdorferi organisms lacking plasmids 25 and 28-1 are internalized by human blood phagocytes at a rate identical to that of the wild-type strain.

Authors:  Samiya Al-Robaiy; Jens Knauer; Reinhard K Straubinger
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  Tick-borne Diseases (Borreliosis, Anaplasmosis, Babesiosis) in German and Austrian Dogs: Status quo and Review of Distribution, Transmission, Clinical Findings, Diagnostics and Prophylaxis.

Authors:  Nikola Pantchev; Silvia Pluta; Elke Huisinga; Stephanie Nather; Miriam Scheufelen; Majda Globokar Vrhovec; Andrea Schweinitz; Herwig Hampel; Reinhard K Straubinger
Journal:  Parasitol Res       Date:  2015-08       Impact factor: 2.289

Review 5.  Antibiotic treatment of animals infected with Borrelia burgdorferi.

Authors:  Gary P Wormser; Ira Schwartz
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

6.  Xenodiagnosis to detect Borrelia burgdorferi infection: a first-in-human study.

Authors:  Adriana Marques; Sam R Telford; Siu-Ping Turk; Erin Chung; Carla Williams; Kenneth Dardick; Peter J Krause; Christina Brandeburg; Christopher D Crowder; Heather E Carolan; Mark W Eshoo; Pamela A Shaw; Linden T Hu
Journal:  Clin Infect Dis       Date:  2014-02-11       Impact factor: 9.079

Review 7.  Chronic Lyme disease: a review.

Authors:  Adriana Marques
Journal:  Infect Dis Clin North Am       Date:  2008-06       Impact factor: 5.982

8.  Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease.

Authors:  Rhonda L LaFleur; Jennifer C Dant; Terri L Wasmoen; Steven M Callister; Dean A Jobe; Steven D Lovrich; Thomas F Warner; O Abdelmagid; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2008-12-03

Review 9.  Reviewing molecular adaptations of Lyme borreliosis spirochetes in the context of reproductive fitness in natural transmission cycles.

Authors:  Jean I Tsao
Journal:  Vet Res       Date:  2009-04-16       Impact factor: 3.683

10.  Quantitative analysis of Borrelia burgdorferi gene expression in naturally (tick) infected mouse strains.

Authors:  Sharon Lederer; Christiane Brenner; Thomas Stehle; Lise Gern; Reinhard Wallich; Markus M Simon
Journal:  Med Microbiol Immunol       Date:  2005-01       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.